October 7, 2026 5:52 pm

Bill Huizenga Faces Scrutiny Over Staff Turned Lobbyists in Election Year

Republican Rep. Bill Huizenga's office has seen over a dozen staffers transition to lobbyists, representing finance, insurance, and pharmaceutical sectors, raising conflict-of-interest concerns.
Huizenga’s revolving door: at least a dozen staffers became lobbyists

Huizenga’s Office: A Hub for Future Lobbyists?

Since 2011, Bill Huizenga has represented Michigan’s 4th District and is now seeking a ninth term. During his tenure, his office has been a stepping stone for at least a dozen individuals who have worked as lobbyists or transitioned into lobbying roles.

Lobbying requires federal registration and the disclosure of clients, and public records reveal that Huizenga’s former staff have engaged in lobbying activities within the finance, insurance, and pharmaceutical sectors.

Among those close to Huizenga was Jon DeWitte, his chief of staff for over ten years, who departed in 2022. DeWitte now holds the position of vice president of government affairs at Travelers Insurance, a firm that has lobbied Congress on topics such as health care, trade, opioids, taxes, and insurance.

In 2023, Heartland Signal reported that Marlis McManus, Huizenga’s former deputy chief of staff, now lobbies for investment giant Vanguard, focusing on investment funds and equity markets. McManus had previously lobbied for the National Association of Mutual Insurance Companies before her tenure with Huizenga.

The phenomenon of moving between public and private sectors, often termed “revolving-door politics,” raises concerns about potential conflicts of interest and corporate influence on legislation.

Other notable transitions include Palmer Rafferty, a former deputy chief of staff who now lobbies for TransUnion, and Martin Van Valkenburg, a past senior advisor who worked for an aerospace company in a lobbying capacity.

These companies, which fall under congressional oversight, operate in sectors overseen by the Financial Services Committee, where Huizenga serves. The industry connections extend to a former senior legislative assistant who now lobbies for pharmaceutical giants Bayer, Eli Lilly, and Novartis.

The Democratic Congressional Campaign Committee has labeled Huizenga as a vulnerable Republican in the upcoming election, with state Sen. Sean McCann challenging him for the seat.

—
Read More Kitchen Table News

Share:

More Posts

Lombardo administration fell short on infant opioid care

Nevada Audit Finds Shortcomings in Infant Opioid Care Under Lombardo

A legislative audit criticized Nevada Gov. Joe Lombardo’s oversight of care plans for opioid-affected infants, revealing lapses in service documentation and monitoring, risking both infant welfare and federal funding. The audit, released in April, highlights the administration’s failure to address these issues, amid Nevada’s minimal progress in reducing overdose deaths.

Send Us A Message

Subscribe